All filters
Abstracts
Time to treatment disfavors patients living with HIV/HCV co-infection
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
Efficacy and safety of sofosbuvir/velpatasvir for the treatment of patients with chronic hepatitis C genotype 1-6 infection: Integrated analysis of eight Phase 3 clinical trials
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
Heterogeneity in priorities for continuing education training among clinicians providing (or not!) HIV and HCV clinical services
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
Automated electrochemiluminescence assay could be used for screening hepatitis B and C markers in dried blood spot samples?
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
96 Week efficacy and safety of B/F/TAF in treatment-naïve adults and adults ≥ 50 years
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
Tenofovir alafenamide vs tenofovir DF in women: Pooled analysis of 7 clinical trials
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
Sociodemographic, health-related factors and behavioral practices among people who inject drugs: Data from the PR NHBS-PWID 3 (2012) and NHBS-PWID 4 (2015)
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
Provider-Initiated HIV testing predictors among heterosexuals at increased risk of HIV in Puerto Rico: Data from NHBS – HET cycle, 2016
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
Hurricane Maria’s viral impact: HIV care outcomes among substance users in Puerto Rico following hurricane Maria
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
Acceptability and concerns over the use of PrEP in Puerto Rico
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
A phase 3b, open-label, pilot study to evaluate switching to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) in virologically suppressed HIV-1 infected adult subjects harboring the NRTI resistance mutation M184V and/or M184I (GS-US
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
Clinical case presentation: A preliminary profile of common co-morbidities and risk practices in a sample of HIV/HCV co-infected patients in Puerto Rico
Presented at:
Puerto Rico Meeting on Hepatitis & HIV 2019
Abstracts
COLDA_2020_abstract_40_Possible Role of Natural Killer Cells in Hepatitis C Virus Related Hepatocellular Carcinoma
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_39_Outcomes of Sorafenib therapy for hepatocellular carcinoma in Ethiopia
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_41_Risks of developing hepatocellular carcinoma in patients with chronic HCV-infection
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_42_Hepatic Resection for Hepatocelullar Carcinoma in Nigeria: a Sigle Centre Experiece from Northwest Nigeria
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_43_Plasminogen Activator Inhibitor Type 1 in Liver Cirrhosis Patients and Non-Alcoholic Steatohepatitis under the Influence of Treatment with Human Albumin Infusion
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_44_Clinical and laboratory predictors of mortality in patients hospitalized for liver cirrhosis in Cameroon
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_45_Devenir au long cours des patients traités par analogues nucléot(s)idiques pour cirrhose virale B à l’Hôpital Principal de Dakar
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_46_Correction of portohepatic hemodynamics disorders and increased ammonia by ornithine at the non-alcoholic steatohepatitis patients without cirrhosis
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_47_Impact of Treating Hyperuricemic NAFLD Patients with Allopurinol on Cytokeratin 18: A Pilot Study
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_48_IL-23 and MMP-9 as predictors of adverse course of psoriasis and NAFLD comorbidities
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_49_Les hépatites auto-immunes à l’Hôpital Principal de Dakar : étude rétrospective à propos de 19 cas.
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Abstracts
COLDA_2020_abstract_50_Hepatorenal Modulatory Effects of Ricinus Communis fractions in Acetaminophen-induced Hepatic-nephrotoxicity in Murine Model
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020